Literature DB >> 27773353

Suicide in Tourette's and Chronic Tic Disorders.

Lorena Fernández de la Cruz1, Mina Rydell2, Bo Runeson3, Gustaf Brander4, Christian Rück3, Brian M D'Onofrio5, Henrik Larsson6, Paul Lichtenstein2, David Mataix-Cols3.   

Abstract

BACKGROUND: Persons with neuropsychiatric disorders are at increased risk of suicide, but there is little data concerning Tourette's and chronic tic disorders (TD/CTD). We aimed to quantify the risk of suicidal behavior in a large nationwide cohort of patients with TD/CTD, establish the contribution of psychiatric comorbidity to this risk, and identify predictors of suicide.
METHODS: Using a validated algorithm, we identified 7736 TD/CTD cases in the Swedish National Patient Register during a 44-year period (1969-2013). Using a matched case-cohort design, patients were compared with general population control subjects (1:10 ratio). Risk of suicidal behavior was estimated using conditional logistic regressions. Predictors of suicidal behavior in the TD/CTD cohort were studied using Cox regression models.
RESULTS: In unadjusted models, TD/CTD patients, compared with control subjects, had an increased risk of both dying by suicide (odds ratio: 4.39; 95% confidence interval [CI]: 2.89-6.67) and attempting suicide (odds ratio: 3.86; 95% CI: 3.50-4.26). After adjusting for psychiatric comorbidities, the risk was reduced but remained substantial. Persistence of tics beyond young adulthood and a previous suicide attempt were the strongest predictors of death by suicide in TD/CTD patients (hazard ratio: 11.39; 95% CI: 3.71-35.02, and hazard ratio: 5.65; 95% CI: 2.21-14.42, respectively).
CONCLUSIONS: TD/CTD are associated with substantial risk of suicide. Suicidal behavior should be monitored in these patients, particularly in those with persistent tics, history of suicide attempts, and psychiatric comorbidities. Preventive and intervention strategies aimed to reduce the suicidal risk in this group are warranted.
Copyright © 2016 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic tic disorder; Premature mortality; Psychiatric epidemiology; Suicide; Suicide attempt; Tourette’s disorder

Mesh:

Year:  2016        PMID: 27773353     DOI: 10.1016/j.biopsych.2016.08.023

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  11 in total

Review 1.  The 5 Pillars in Tourette Syndrome Deep Brain Stimulation Patient Selection: Present and Future.

Authors:  Davide Martino; Wissam Deeb; Joohi Jimenez-Shahed; Irene Malaty; Tamara M Pringsheim; Alfonso Fasano; Christos Ganos; Winifred Wu; Michael S Okun
Journal:  Neurology       Date:  2021-02-16       Impact factor: 9.910

2.  Course of tic disorders over the lifespan.

Authors:  Kevin J Black; Soyoung Kim; Nancy Y Yang; Deanna J Greene
Journal:  Curr Dev Disord Rep       Date:  2021-04-10

Review 3.  Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.

Authors:  Tamara Pringsheim; Michael S Okun; Kirsten Müller-Vahl; Davide Martino; Joseph Jankovic; Andrea E Cavanna; Douglas W Woods; Michael Robinson; Elizabeth Jarvie; Veit Roessner; Maryam Oskoui; Yolanda Holler-Managan; John Piacentini
Journal:  Neurology       Date:  2019-05-07       Impact factor: 11.800

4.  Tourette syndrome research highlights from 2017.

Authors:  Andreas Hartmann; Yulia Worbe; Kevin J Black
Journal:  F1000Res       Date:  2018-07-23

5.  Tackle your Tics: pilot findings of a brief, intensive group-based exposure therapy program for children with tic disorders.

Authors:  A P Heijerman-Holtgrefe; C W J Verdellen; J M T M van de Griendt; L P L Beljaars; K J Kan; D Cath; P J Hoekstra; C Huyser; E M W J Utens
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-05-20       Impact factor: 4.785

6.  Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.

Authors:  Barbara Coffey; Joseph Jankovic; Daniel O Claassen; Joohi Jimenez-Shahed; Barry J Gertz; Elizabeth A Garofalo; David A Stamler; Maria Wieman; Juha-Matti Savola; Mark Forrest Gordon; Jessica K Alexander; Hadas Barkay; Eran Harary
Journal:  JAMA Netw Open       Date:  2021-10-01

Review 7.  European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment.

Authors:  Veit Roessner; Heike Eichele; Jeremy S Stern; Liselotte Skov; Renata Rizzo; Nanette Mol Debes; Péter Nagy; Andrea E Cavanna; Cristiano Termine; Christos Ganos; Alexander Münchau; Natalia Szejko; Danielle Cath; Kirsten R Müller-Vahl; Cara Verdellen; Andreas Hartmann; Aribert Rothenberger; Pieter J Hoekstra; Kerstin J Plessen
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-11-10       Impact factor: 4.785

8.  Efficacy of deep brain stimulation of the anterior-medial globus pallidus internus in tic and non-tic related symptomatology in refractory Tourette syndrome.

Authors:  Raven Kisten; Riaan van Coller; Nafisa Cassimjee; Elsa Lubbe; Janardan Vaidyanathan; Pieter Slabbert; Nico Enslin; Clara Schutte
Journal:  Clin Park Relat Disord       Date:  2022-08-03

9.  Improved depressive symptoms in patients with refractory Gilles de la Tourette syndrome after deep brain stimulation of posteroventral globus pallidus interna.

Authors:  Aijun Liu; Yongcheng Jiao; Shaohui Zhang; Haibo Kong
Journal:  Brain Behav       Date:  2022-05-27       Impact factor: 3.405

Review 10.  Tourette syndrome research highlights from 2018.

Authors:  Olivia Rose; Andreas Hartmann; Yulia Worbe; Jeremiah M Scharf; Kevin J Black
Journal:  F1000Res       Date:  2019-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.